Ami Bavishi
Investor Relations Contact bij RALLYBIO CORPORATION
Profiel
Ami Bavishi is currently the Head of Investor Relations & Corporate Communications at Rallybio Corp.
Prior to this, he worked as the Director of Investor Relations at Aerie Pharmaceuticals, Inc. Mr. Bavishi has a graduate degree from George Washington University and an undergraduate degree from Duquesne University of The Holy Spirit.
Actieve functies van Ami Bavishi
| Bedrijven | Functie | Begin |
|---|---|---|
| RALLYBIO CORPORATION | Investor Relations Contact | 18-01-2022 |
Eerdere bekende functies van Ami Bavishi
| Bedrijven | Functie | Einde |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Opleiding van Ami Bavishi
| George Washington University | Graduate Degree |
| Duquesne University of The Holy Spirit | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
